In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

Novo Nordisk (CPSE:NOVO B) has entered a new $2.1b partnership with Vivtex to develop next generation oral biologic drugs for obesity and diabetes. The collaboration targets oral versions of medicines ...

Feb 25 (Reuters) - Danish drugmaker Novo Nordisk has partnered with U.S.-based Vivtex Corp in a deal worth up to $2.1 billion ...

When prescription prices keep climbing, patients are forced into impossible decisions — skipping doses, delaying treatment or choosing between medication and other basic needs. For people with Crohn’s ...

University of Texas Medical Branch launches new anti-aging study: Can weight loss medications slow biological aging?

The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...

If you have moderate to severe ulcerative colitis (UC) and haven’t found enough relief from traditional medications, your doctor may talk to you about biologics. These newer drugs, which include ...

Biologic drugs have improved how doctors treat serious illnesses. Instead of being made from chemicals, biologics are made from organic materials and grown in living cells. Biologic drugs are used ...

Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...

When people struggle with anxiety and depression, the most effective approach is often to combine medication and ...